Prognostic factors in elderly patients with malignant pleural mesothelioma: Results of a multicenter survey

G. L. Ceresoli; F. Grosso; P. A. Zucali; M. Mencoboni; G. Pasello; C. Ripa; D. Degiovanni; M. Simonelli; A. Bruzzone; C. Dipietrantonj; E. Piccolini; G. D. Beretta; A. G. Favaretto; L. Giordano; A. Santoro; M. Botta

doi:10.1038/bjc.2014.312

Prognostic factors in elderly patients with malignant pleural mesothelioma: Results of a multicenter survey

G. L. Ceresoli, F. Grosso, P. A. Zucali, M. Mencoboni, G. Pasello, C. Ripa, D. Degiovanni, M. Simonelli, A. Bruzzone, C. Dipietrantonj, E. Piccolini, G. D. Beretta, A. G. Favaretto, L. Giordano, A. Santoro, M. Botta

Research output: Contribution to journal › Article › peer-review

Abstract

Background:The incidence of malignant pleural mesothelioma (MPM) in elderly patients is increasing. There are no specific guidelines for their management.Methods:The clinical records of elderly patients (≥70 years old) with MPM referred from January 2005 to November 2011 to six Italian Centres were reviewed. Age, gender, histology, International Mesothelioma Interest Group (IMIG) stage, Eastern Cooperative Oncology Group Performance Status (ECOG-PS), Charlson Comorbidity Index (CCI) and treatment modalities were analysed and correlated to overall survival (OS).Results:In total, 241 patients were identified. Charlson Comorbidity Index was ≥1 in 92 patients (38%). Treatment was multimodality therapy including surgery in 18, chemotherapy alone in 180 (75%) and best supportive care in 43 cases (18%). Chemotherapy was mainly pemetrexed based. Median OS was 11.4 months. Non-epithelioid histology (HR 2.32; 95% CI 1.66-3.23, P

Original language	English
Pages (from-to)	220-226
Number of pages	7
Journal	British Journal of Cancer
Volume	111
Issue number	2
DOIs	https://doi.org/10.1038/bjc.2014.312
Publication status	Published - Jul 15 2014

Keywords

Charlson Index
comorbidity
elderly
pemetrexed
pleural mesothelioma

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.1038/bjc.2014.312

Cite this

Ceresoli, G. L., Grosso, F., Zucali, P. A., Mencoboni, M., Pasello, G., Ripa, C., Degiovanni, D., Simonelli, M., Bruzzone, A., Dipietrantonj, C., Piccolini, E., Beretta, G. D., Favaretto, A. G., Giordano, L., Santoro, A., & Botta, M. (2014). Prognostic factors in elderly patients with malignant pleural mesothelioma: Results of a multicenter survey. British Journal of Cancer, 111(2), 220-226. https://doi.org/10.1038/bjc.2014.312

Ceresoli, GL, Grosso, F, Zucali, PA, Mencoboni, M, Pasello, G, Ripa, C, Degiovanni, D, Simonelli, M, Bruzzone, A, Dipietrantonj, C, Piccolini, E, Beretta, GD, Favaretto, AG, Giordano, L , Santoro, A & Botta, M 2014, 'Prognostic factors in elderly patients with malignant pleural mesothelioma: Results of a multicenter survey', British Journal of Cancer, vol. 111, no. 2, pp. 220-226. https://doi.org/10.1038/bjc.2014.312

@article{b9afc1ddea2a4f7d9fb7294892d11124,

title = "Prognostic factors in elderly patients with malignant pleural mesothelioma: Results of a multicenter survey",

abstract = "Background:The incidence of malignant pleural mesothelioma (MPM) in elderly patients is increasing. There are no specific guidelines for their management.Methods:The clinical records of elderly patients (≥70 years old) with MPM referred from January 2005 to November 2011 to six Italian Centres were reviewed. Age, gender, histology, International Mesothelioma Interest Group (IMIG) stage, Eastern Cooperative Oncology Group Performance Status (ECOG-PS), Charlson Comorbidity Index (CCI) and treatment modalities were analysed and correlated to overall survival (OS).Results:In total, 241 patients were identified. Charlson Comorbidity Index was ≥1 in 92 patients (38%). Treatment was multimodality therapy including surgery in 18, chemotherapy alone in 180 (75%) and best supportive care in 43 cases (18%). Chemotherapy was mainly pemetrexed based. Median OS was 11.4 months. Non-epithelioid histology (HR 2.32; 95% CI 1.66-3.23, P",

keywords = "Charlson Index, comorbidity, elderly, pemetrexed, pleural mesothelioma",

author = "Ceresoli, {G. L.} and F. Grosso and Zucali, {P. A.} and M. Mencoboni and G. Pasello and C. Ripa and D. Degiovanni and M. Simonelli and A. Bruzzone and C. Dipietrantonj and E. Piccolini and Beretta, {G. D.} and Favaretto, {A. G.} and L. Giordano and A. Santoro and M. Botta",

year = "2014",

month = jul,

day = "15",

doi = "10.1038/bjc.2014.312",

language = "English",

volume = "111",

pages = "220--226",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Prognostic factors in elderly patients with malignant pleural mesothelioma

T2 - Results of a multicenter survey

AU - Ceresoli, G. L.

AU - Grosso, F.

AU - Zucali, P. A.

AU - Mencoboni, M.

AU - Pasello, G.

AU - Ripa, C.

AU - Degiovanni, D.

AU - Simonelli, M.

AU - Bruzzone, A.

AU - Dipietrantonj, C.

AU - Piccolini, E.

AU - Beretta, G. D.

AU - Favaretto, A. G.

AU - Giordano, L.

AU - Santoro, A.

AU - Botta, M.

PY - 2014/7/15

Y1 - 2014/7/15

N2 - Background:The incidence of malignant pleural mesothelioma (MPM) in elderly patients is increasing. There are no specific guidelines for their management.Methods:The clinical records of elderly patients (≥70 years old) with MPM referred from January 2005 to November 2011 to six Italian Centres were reviewed. Age, gender, histology, International Mesothelioma Interest Group (IMIG) stage, Eastern Cooperative Oncology Group Performance Status (ECOG-PS), Charlson Comorbidity Index (CCI) and treatment modalities were analysed and correlated to overall survival (OS).Results:In total, 241 patients were identified. Charlson Comorbidity Index was ≥1 in 92 patients (38%). Treatment was multimodality therapy including surgery in 18, chemotherapy alone in 180 (75%) and best supportive care in 43 cases (18%). Chemotherapy was mainly pemetrexed based. Median OS was 11.4 months. Non-epithelioid histology (HR 2.32; 95% CI 1.66-3.23, P

AB - Background:The incidence of malignant pleural mesothelioma (MPM) in elderly patients is increasing. There are no specific guidelines for their management.Methods:The clinical records of elderly patients (≥70 years old) with MPM referred from January 2005 to November 2011 to six Italian Centres were reviewed. Age, gender, histology, International Mesothelioma Interest Group (IMIG) stage, Eastern Cooperative Oncology Group Performance Status (ECOG-PS), Charlson Comorbidity Index (CCI) and treatment modalities were analysed and correlated to overall survival (OS).Results:In total, 241 patients were identified. Charlson Comorbidity Index was ≥1 in 92 patients (38%). Treatment was multimodality therapy including surgery in 18, chemotherapy alone in 180 (75%) and best supportive care in 43 cases (18%). Chemotherapy was mainly pemetrexed based. Median OS was 11.4 months. Non-epithelioid histology (HR 2.32; 95% CI 1.66-3.23, P

KW - Charlson Index

KW - comorbidity

KW - elderly

KW - pemetrexed

KW - pleural mesothelioma

UR - http://www.scopus.com/inward/record.url?scp=84904576554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904576554&partnerID=8YFLogxK

U2 - 10.1038/bjc.2014.312

DO - 10.1038/bjc.2014.312

M3 - Article

C2 - 24918816

AN - SCOPUS:84904576554

SN - 0007-0920

VL - 111

SP - 220

EP - 226

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 2

ER -

Prognostic factors in elderly patients with malignant pleural mesothelioma: Results of a multicenter survey

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this